Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.

Rashidghamat E, McGrath JA.

Intractable Rare Dis Res. 2017 Feb;6(1):6-20. doi: 10.5582/irdr.2017.01005. Review.

2.

CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa.

Webber BR, Osborn MJ, McElroy AN, Twaroski K, Lonetree CL, DeFeo AP, Xia L, Eide C, Lees CJ, McElmurry RT, Riddle MJ, Kim CJ, Patel DD, Blazar BR, Tolar J.

NPJ Regen Med. 2016;1. pii: 16014. doi: 10.1038/npjregenmed.2016.14. Epub 2016 Dec 8.

3.

Induction of Skin-Derived Precursor Cells from Human Induced Pluripotent Stem Cells.

Sugiyama-Nakagiri Y, Fujimura T, Moriwaki S.

PLoS One. 2016 Dec 19;11(12):e0168451. doi: 10.1371/journal.pone.0168451. eCollection 2016.

4.

Modeling Cancer with Pluripotent Stem Cells.

Gingold J, Zhou R, Lemischka IR, Lee DF.

Trends Cancer. 2016 Sep;2(9):485-494. Epub 2016 Aug 21.

PMID:
27722205
5.

Current progress of skin tissue engineering: Seed cells, bioscaffolds, and construction strategies.

Bi H, Jin Y.

Burns Trauma. 2013 Sep 18;1(2):63-72. doi: 10.4103/2321-3868.118928. eCollection 2013.

6.

CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia.

Osborn M, Lonetree CL, Webber BR, Patel D, Dunmire S, McElroy AN, DeFeo AP, MacMillan ML, Wagner J, Balzar BR, Tolar J.

Stem Cells Dev. 2016 Aug 18. [Epub ahead of print]

PMID:
27538887
7.

Direct conversion of mouse embryonic fibroblasts into functional keratinocytes through transient expression of pluripotency-related genes.

Iacovides D, Rizki G, Lapathitis G, Strati K.

Stem Cell Res Ther. 2016 Jul 29;7(1):98. doi: 10.1186/s13287-016-0357-5.

8.

hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine.

Sabapathy V, Kumar S.

J Cell Mol Med. 2016 Aug;20(8):1571-88. doi: 10.1111/jcmm.12839. Epub 2016 Apr 21. Review.

9.

Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.

Perdoni C, Osborn MJ, Tolar J.

Transl Res. 2016 Feb;168:50-8. doi: 10.1016/j.trsl.2015.05.008. Epub 2015 May 27. Review.

10.

Transcriptional profiling of ectoderm specification to keratinocyte fate in human embryonic stem cells.

Tadeu AM, Lin S, Hou L, Chung L, Zhong M, Zhao H, Horsley V.

PLoS One. 2015 Apr 7;10(4):e0122493. doi: 10.1371/journal.pone.0122493. eCollection 2015.

11.

From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa.

Webber BR, Tolar J.

Mol Ther. 2015 Jun;23(6):987-92. doi: 10.1038/mt.2015.47. Epub 2015 Mar 24. Review.

12.

Placenta-based therapies for the treatment of epidermolysis bullosa.

Nevala-Plagemann C, Lee C, Tolar J.

Cytotherapy. 2015 Jun;17(6):786-95. doi: 10.1016/j.jcyt.2015.03.006. Epub 2015 Mar 18. Review.

13.

A single epidermal stem cell strategy for safe ex vivo gene therapy.

Droz-Georget Lathion S, Rochat A, Knott G, Recchia A, Martinet D, Benmohammed S, Grasset N, Zaffalon A, Besuchet Schmutz N, Savioz-Dayer E, Beckmann JS, Rougemont J, Mavilio F, Barrandon Y.

EMBO Mol Med. 2015 Apr;7(4):380-93. doi: 10.15252/emmm.201404353.

14.

The three-body problem of therapy with induced pluripotent stem cells.

Tolar J, McGrath JA.

Genome Med. 2015 Feb 20;7(1):15. doi: 10.1186/s13073-015-0141-7. eCollection 2015.

15.

Induced pluripotent stem cell potential in medicine, specifically focused on reproductive medicine.

Botman O, Wyns C.

Front Surg. 2014 Mar 24;1:5. doi: 10.3389/fsurg.2014.00005. eCollection 2014. Review.

16.

Induced pluripotent stem cells in dermatology: potentials, advances, and limitations.

Bilousova G, Roop DR.

Cold Spring Harb Perspect Med. 2014 Nov 3;4(11):a015164. doi: 10.1101/cshperspect.a015164. Review.

17.

Cell therapy in dermatology.

Petrof G, Abdul-Wahab A, McGrath JA.

Cold Spring Harb Perspect Med. 2014 Jun 2;4(6). pii: a015156. doi: 10.1101/cshperspect.a015156. Review.

18.

Advances in understanding and treating dystrophic epidermolysis bullosa.

Vanden Oever MJ, Tolar J.

F1000Prime Rep. 2014 May 6;6:35. doi: 10.12703/P6-35. eCollection 2014. Review.

19.

Modeling AEC-New approaches to study rare genetic disorders.

Koch PJ, Dinella J, Fete M, Siegfried EC, Koster MI.

Am J Med Genet A. 2014 Oct;164A(10):2443-54. doi: 10.1002/ajmg.a.36455. Epub 2014 Mar 24. Review.

20.

Integrating animal models and in vitro tissue models to elucidate the role of desmosomal proteins in diseases.

Koster MI, Dinella J, Chen J, O'Shea C, Koch PJ.

Cell Commun Adhes. 2014 Feb;21(1):55-63. doi: 10.3109/15419061.2013.876015. Review.

Supplemental Content

Support Center